CLINICAL-FEATURE IN PATIENTS WITH HOMOZYGOUS AND HETEROZYGOUS FACTOR-V LEIDEN MUTATION (APC-RESISTANCE) AND A HISTORY OF VENOUS THROMBOEMBOLISM

被引：0
|
作者：
RINTELEN, C
BAYSTON, TA
IRELAND, H
LANE, DA
MANNHALTER, C
PABINGER, I
机构：
[1] UNIV HOSP VIENNA,CLIN INST LAB MED,VIENNA,AUSTRIA
[2] CHARING CROSS & WESTMINSTER MED SCH,DEPT HAEMATOL,LONDON,ENGLAND
[3] UNIV HOSP VIENNA,MED CLIN I,DEPT HAEMATOL & BLOOD COAGULANT,VIENNA,AUSTRIA
来源：
THROMBOSIS AND HAEMOSTASIS | 1995年 / 73卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1124 / 1124
页数：1
相关论文
共 50 条
  • [21] Apixaban Failure for Venous Thromboembolism Treatment with Heterozygous Factor V Leiden
    Albanese, S.
    Pilcher, M. B.
    Hutchison, L. C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 : S257 - S258
  • [22] Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation
    Brugge, JM
    Simoni, PS
    Bernardi, F
    Tormene, D
    Lunghi, B
    Tans, G
    Pagnan, A
    Rosing, J
    Castoldi, E
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (12) : 2695 - 2702
  • [23] The factor V Leiden mutation and the risk of venous thromboembolism in gynecologic oncology patients
    Ravin, AJ
    Edwards, RP
    Krohn, MA
    Kelley, JR
    Christopherson, WA
    Roberts, JM
    OBSTETRICS AND GYNECOLOGY, 2002, 100 (06): : 1285 - 1289
  • [24] FACTOR V LEIDEN MUTATION INCREASES THE RISK FOR VENOUS THROMBOEMBOLISM IN PATIENTS WITH MALIGNANCY
    Pabinger, I.
    Dunkler, D.
    Vormittag, R.
    Ay, C.
    Marosi, C.
    Simanek, R.
    Zielinski, C. C.
    Mannhalter, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 212 - 212
  • [25] Factor V Leiden mutation increases the risk for venous thromboembolism in patients with malignancy
    Pabinger, I
    Dunkler, D.
    Vormittag, R.
    Ay, C.
    Marosi, C.
    Simanek, R.
    Zielinski, C.
    Mannhalter, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 427 - 427
  • [26] Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: A focus on the Factor V Leiden mutation
    Manten, B
    Westendorp, RGJ
    Koster, T
    Reitsma, PH
    Rosendaal, FR
    THROMBOSIS AND HAEMOSTASIS, 1996, 76 (04) : 510 - 513
  • [27] Risk for venous thromboembolism in carriers of the factor V Leiden mutation
    Orwoll, RL
    ANNALS OF INTERNAL MEDICINE, 2003, 138 (01) : 76 - 76
  • [28] Recurrent venous thromboembolism is associated with Factor V Leiden mutation
    Sveinsdottir, S., V
    Saemundsson, Y.
    Isma, N.
    Gottsater, A.
    Svensson, P. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 734 - 734
  • [29] CLINICAL AND LABORATORY DATA IN HETEROZYGOUS FACTOR-V LEIDEN MUTATION POSITIVE VERSUS NEGATIVE PATIENTS WITH TIA AND MINOR STROKE
    LALOUSCHEK, W
    SUESS, E
    AULL, S
    SCHNIDER, P
    UHL, F
    ZEILER, K
    PABINGERFASCHING, I
    STROKE, 1995, 26 (10) : 1963 - 1964
  • [30] Venous thromboembolism at a young age in a brother and sister with coinheritance of homozygous 20210A/A prothrombin mutation and heterozygous 1691G/A factor V Leiden mutation
    Halbmayer, WM
    Kalhs, T
    Haushofer, A
    Breier, F
    Fischer, M
    BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (05) : 297 - 302
12345